Your browser version may not work well with NCBI's Web applications. More information here...
1: N Engl J Med. 2008 Sep 11;359(11):1128-35.
Related Articles, Links
Click here to read Click here to read
Comment in:
NHERF1 mutations and responsiveness of renal parathyroid hormone.

Karim Z, Gérard B, Bakouh N, Alili R, Leroy C, Beck L, Silve C, Planelles G, Urena-Torres P, Grandchamp B, Friedlander G, Prié D.

INSERM Unité 845, Université Paris Descartes, Faculté de Médecine, Paris, France.

Impaired renal phosphate reabsorption, as measured by dividing the tubular maximal reabsorption of phosphate by the glomerular filtration rate (TmP/GFR), increases the risks of nephrolithiasis and bone demineralization. Data from animal models suggest that sodium-hydrogen exchanger regulatory factor 1 (NHERF1) controls renal phosphate transport. We sequenced the NHERF1 gene in 158 patients, 94 of whom had either nephrolithiasis or bone demineralization. We identified three distinct mutations in seven patients with a low TmP/GFR value. No patients with normal TmP/GFR values had mutations. The mutants expressed in cultured renal cells increased the generation of cyclic AMP (cAMP) by parathyroid hormone (PTH) and inhibited phosphate transport. These NHERF1 mutations suggest a previously unrecognized cause of renal phosphate loss in humans. 2008 Massachusetts Medical Society

Publication Types:
PMID: 18784102 [PubMed - indexed for MEDLINE]